Noted Vaccine Researcher and Leader Kate O'Brien Awarded Sabin's Gold Medal; Physician Livancliff Mbianke of Cameroon Receives Rising Star Award
O'Brien is a pioneering global health leader whose innovative work in vaccine access and policy has transformed immunization programs worldwide.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
17 hours ago
- Toronto Star
The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research
Philadelphia, PA, Aug. 19, 2025 (GLOBE NEWSWIRE) — The Wistar Institute announces the National Institutes of Health (NIH) granted a five-year, $17 million research award to launch iCure Consortium to develop individualized 'cure regimens' for HIV. The Wistar-led, iCure Consortium's objective is to advance strategies to cure HIV through tailored personalized medicine. 'Today 38 million people still live with HIV worldwide, and 1.3 million contract the virus each year,' said Luis J. Montaner, D.V.M., iCure principal investigator, executive vice president of The Wistar Institute and director of Wistar's HIV Cure and Viral Diseases Center. 'For the first time, this grant brings our best team together working towards a cure tailored to each participant by pairing the latest in neutralizing antibody and cell-therapy breakthroughs against the unique, person-specific features of HIV.'
Toronto Star
a day ago
- Toronto Star
BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic's IzoView Device
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ('Izotropic', or the 'Company'), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the launch of a new online platform supporting the Company's awareness initiatives. has been created as a central educational resource on dedicated breast CT technology and the Company's IzoView Breast CT Imaging System, with a focus on its potential to address persistent challenges in detecting breast cancer in the 50% of women with dense breast tissue. With IzoView's engineering complete, the site is designed to evolve alongside the Company through clinical study preparation, U.S. and global regulatory phases, and ongoing education and awareness initiatives leading to commercial launch.
Toronto Star
a day ago
- Toronto Star
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will participate in the following upcoming investor conferences: Citi's Biopharma Back to School Conference: Zymeworks' management will participate in one-on-one meetings on September 3 in Boston, MA. Wells Fargo Healthcare Conference: Zymeworks' management will participate in one-on-one meetings and a fireside chat on September 4 at 4:30 pm Eastern Time (ET) in Boston, MA. Cantor Global Healthcare Conference: Zymeworks' management will participate in one-on-one meetings and a fireside chat on September 5 at 8:35 am ET in New York, NY. Morgan Stanley Annual Global Healthcare Conference: Zymeworks' management will participate in one-on-one meetings and a fireside chat on September 8 at 3:20 pm ET in New York, NY.
